Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Tyrosine Kinases

SU 6668, PDGFR inhibitor (ab142156)

Description:
Potent PDGFR inhibitor
Application:
Reactivity:
Conjugate:

Tyrphostin 47, EGFR tyrosine kinase inhibitor (ab141558)

Description:
EGFR tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:

Tyrphostin 9, PDGFR tyrosine kinase inhibitor (ab141561)

Description:
Selective PDGFR tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:
Product image

Human Met (c-Met) ELISA Kit (ab277722)

Description:
Human Met (c-Met) ELISA Kit
Application:
Reactivity:
Human
Conjugate:
Product image

Human Met Antibody Pair - BSA and Azide free (c-Met) (ab253495)

Description:
Human Met Antibody Pair - BSA and Azide free (c-Met)
Application:
Reactivity:
Human
Conjugate:

Anti-Met (c-Met) antibody - BSA and Azide free (Capture) (ab278027)

Description:
Rabbit monoclonal to Met (c-Met) - BSA and Azide free (Capture)
Application:
sELISA
Reactivity:
Human
Conjugate:
Unconjugated

Anti-Met (c-Met) antibody - BSA and Azide free (Detector) (ab278028)

Description:
Rabbit monoclonal to Met (c-Met) - BSA and Azide free (Detector)
Application:
sELISA
Reactivity:
Human
Conjugate:
Unconjugated
  • ‹
  • 1
  • 2
  • ...
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • ›
Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.